Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways

Biochemistry

Volumn 48, Issue 44, 2009, Pages 10591-10600

  León, Rafael ^a   Murray, Jill I ^a   Cragg, Gina ^a   Farnell, Benjamin ^a   West, Nathan R ^b   Pace, Tamara C S ^a   Watson, Peter H ^b   Bohne, Cornelia ^a   Boulanger, Martin J ^a   Hof, Fraser ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING CLEFTS; BINDING INTERACTION; COMPLEX INTERACTION; FLUORESCENCE LIFETIMES; FLUORESCENT DYES; HOMODIMERS; HYDROPHOBIC POCKETS; HYDROPHOBIC SITES; ISOTHERMAL TITRATION CALORIMETRY; N-TERMINALS; SIGNALING PROTEINS; SMALL MOLECULE INHIBITOR; SMALL MOLECULES; STEADY-STATE FLUORESCENCE; SURFACE BINDING; THERAPEUTIC TARGETS; TIME-RESOLVED FLUORESCENCE; TRIPLE MUTANTS; YEAST TWO HYBRID;

BINDING ENERGY; CONFORMATIONS; FLUORESCENCE; HYDROPHOBICITY; MOLECULES; NAPHTHALENE; PATHOLOGY; PROBES;

BINDING SITES;

NAPHTHALENE; PSORIASIN;

AMINO TERMINAL SEQUENCE; ARTICLE; DRUG BINDING SITE; FLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; STEADY STATE;

BINDING SITES; CALORIMETRY; CRYSTALLOGRAPHY, X-RAY; FLUORESCENCE; HUMANS; INFLAMMATION; MODELS, MOLECULAR; NEOPLASMS; PROTEIN CONFORMATION; S100 PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES;

PYRONIA TITHONUS;

EID: 70449399336     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi901330g     Document Type: Article

References (58)

1. Marenholz, I., Heizmann, C. W., and Fritz,G. (2004) S100 proteins in mouse and man: From evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun. 322, 1111-1122.
2. Engelkamp, D., Schafer, B. W., Mattei, M. G., Erne, P., and Heizmann, C. W. (1993) Six S100 genes are clustered on human chromosome 1q21: Identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc. Natl. Acad. Sci. U.S.A. 90, 6547-6551.
3. Schafer, B. W., Wicki, R., Engelkamp, D., Mattei, M. G., and Heizmann, C. W. (1995) Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: Rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 25, 638-643.
4. Sturchler, E., Cox, J. A., Durussel, I., Weibel, M., and Heizmann, C. W. (2006) S100A16, a novel calcium-binding protein of the EF-hand superfamily. J. Biol. Chem. 281, 38905-38917.
5. Madsen, P., Rasmussen,H. H., Leffers, H., Honore, B., Dejgaard, K., Olsen, E., Kiil, J., Walbum, E., Andersen, A. H., and Basse, B.; et al. (1991) Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J. Invest. Dermatol. 97, 701-712.
6. Boniface, K., Bernard, F.-X., Garcia, M., Gurney, A. L., Lecron, J.-C., and Morel, F. (2005) IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes. J. Immunol. 174, 3695-3702.
7. Boniface, K., Diveu, C., Morel, F., Pedretti, N., Froger, J., Ravon, E., Garcia, M., Venereau, E., Preisser, L., Guignouard, E., Guillet, G., Dagregorio, G., Pene, J., Moles, J.-P., Yssel, H., Chevalier, S., Bernard, F.-X., Gascan, H., and Lecron, J.-C. (2007) Oncostatin M Secreted by Skin Infiltrating T Lymphocytes Is a Potent Keratinocyte Activator Involved in Skin Inflammation. J. Immunol. 178, 4615-4622. (Pubitemid 46492414)
8. Wolf, R., Howard, O. M. Z., Dong, H.-F., Voscopoulos, C., Boeshans, K., Winston, J., Divi, R., Gunsior, M., Goldsmith, P., Ahvazi, B., Chavakis, T., Oppenheim, J. J., and Yuspa, S. H. (2008) Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15. J. Immunol. 181, 1499-1506.
9. Glaser, R., Harder, J., Lange, H., Bartels, J., Christophers, E., and Schroder, J.-M. (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol. 6, 57.
10. Lee, K. C., and Eckert, R. L. (2006) S100A7 (Psoriasin): Mechanism of Antibacterial Action in Wounds. J. Invest. Dermatol. 127, 945.
11. Zhang, H., Zhao, Q., Chen, Y., Wang, Y., Gao, S., Mao, Y., Li, M., Peng, A., He, D., and Xiao, X. (2008) Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax 63, 352-359.
12. Celis, J. E., Rasmussen, H. H., Vorum, H., Madsen, P., Honore, B., Wolf, H., and Orntoft, T. F. (1996) Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J. Urol. 155, 2105-2112. (Pubitemid 26146716)
13. Ralhan, R., DeSouza, L. V., Matta, A., Chandra Tripathi, S., Ghanny, S., Datta Gupta, S., Bahadur, S., and Siu, K. W. M. (2008) Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry. Mol. Cell. Proteomics 7, 1162-1173.
14. Webb, M., Emberley, E. D., Lizardo, M., Alowami, S., Qing, G., Alfia'ar, A., Snell-Curtis, L. J., Niu, Y., Civetta, A., Myal, Y., Shiu, R., Murphy, L. C., and Watson, P. H. (2005) Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. BMC Cancer 5, 17.
15. El-Rifai, W., Moskaluk, C. A., Abdrabbo, M. K., Harper, J., Yoshida, C., Riggins, G. J., Frierson, H. F.Jr., and Powell, S. M. (2002) Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 62, 6823-6826. (Pubitemid 35424067)
16. Brouard, M. C., Saurat, J. H., Ghanem, G., and Siegenthaler, G. (2002) Urinary excretion of epidermal-type fatty acid-binding protein and S100A7 protein in patients with cutaneous melanoma. Melanoma Res. 12, 627-631. (Pubitemid 36042750)
17. Moog-Lutz, C., Bouillet, P., Regnier, C. H., Tomasetto, C., Mattei, M. G., Chenard,M. P., Anglard, P., Rio, M. C., and Basset, P. (1995) Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. Int. J. Cancer 63, 297-303.
18. Enerback, C., Porter, D. A., Seth, P., Sgroi, D., Gaudet, J., Weremowicz, S., Morton, C. C., Schnitt, S., Pitts, R. L., Stampl, J., Barnhart, K., and Polyak, K. (2002) Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res. 62, 43-47. (Pubitemid 34073983)
19. Leygue, E., Snell, L., Hiller, T., Dotzlaw, H., Hole, K., Murphy, L. C., and Watson, P. H. (1996) Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res. 56, 4606-4609. (Pubitemid 26338057)
20. Mandal, S., Curtis, L., Pind, M., Murphy, L. C., and Watson, P. H. (2007) S100A7 (psoriasin) influences immune response genes in human breast cancer. Exp. Cell Res. 313, 3016-3025.
21. Santamaria-kisiel, L., Rintala-dempsey, A. C., and Shaw, G. S. (2006) Calcium-dependent and -independent interactions of the S100 protein family. Biochem. J. 396, 201-214. (Pubitemid 43837235)
22. Emberley, E., Gietz, R. D., Campbell, J. D., HayGlass, K., Murphy, L., and Watson, P. (2002) RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer. BMC Cancer 2, 28.
23. Ruse, M., Lambert, A., Robinson, N., Ryan, D., Shon, K. J., and Eckert, R. L. (2001) S100A7, S100A10, and S100A11 Are Transglutaminase Substrates. Biochemistry 40, 3167-3173.
24. Hagens, G., Masouyé, I., Augsburger, E., Hotz, R., Saurat, J. H., and Siegenthaler, G. (1999) Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes. Biochem. J. 339, 419-427. (Pubitemid 29209974)
25. Ruse, M., Broome, A.-M., and Eckert, R. L. (2003) S100A7 (Psoriasin) Interacts with Epidermal Fatty Acid Binding Protein and Localizes in Focal Adhesion-Like Structures in Cultured Keratinocytes. J. Invest. Dermatol. 121, 132-141.
26. Emberley, E. D., Niu, Y., Leygue, E., Tomes, L., Gietz, R. D., Murphy, L. C., and Watson, P. H. (2003) Psoriasin Interacts with Jab1 and Influences Breast Cancer Progression. Cancer Res. 63, 1954-1961. (Pubitemid 36460863)
27. Emberley, E. D., Niu, Y., Curtis, L., Troup, S., Mandal, S. K., Myers, J. N., Gibson, S. B., Murphy, L. C., and Watson, P. H. (2005) The S100A7-c-Jun Activation Domain Binding Protein 1 Pathway Enhances Prosurvival Pathways in Breast Cancer. Cancer Res. 65, 5696-5702.
28. Emberley, E. D., Alowami, S., Snell, L., Murphy, L. C., and Watson, P. H. (2004) S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. Breast Cancer Res. 6, R308-R315.
29. Paruchuri, V., Prasad, A., McHugh, K., Bhat, H. K., Polyak, K., and Ganju, R. K. (2008) S100A7-Downregulation Inhibits Epidermal Growth Factor-Induced Signaling in Breast Cancer Cells and Blocks Osteoclast Formation. PLoS ONE 3, e1741. (Pubitemid 351907750)
30. Wang, J., Barnes, R., West, N., Olson, M., Chu, J., and Watson, P. (2008) Jab1 is a target of EGFR signaling in ERα-negative breast cancer. Breast Cancer Res. 10, R51.
31. Jinquan, T., Vorum, H., Larsen, C., Madsen, P., Rasmussen, H., Gesser, B., Etzerodt, M., Honore, B., Celis, J., and Thestrup-Pedersen, K. (1996) Psoriasin: A novel chemotactic protein. J. Invest. Dermatol. 107, 5-10.
32. Jiang, W. G., Watkins, G., Douglas-Jones, A., and Mansel, R. E. (2004) Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes. Int. J. Oncol. 25, 81-85.
33. Brodersen, D. E., Etzerodt, M., Madsen, P., Celis, J. E., Thogersen, H. C., Nyborg, J., and Kjeldgaard, M. (1998) EF-hands at atomic resolution: The structure of human psoriasin (S100A7) solved by MAd phasing. Structure 6, 477-489.
34. 2+-free states. Biochemistry 38, 1695-1704.
35. Markowitz, J., Chen, I., Gitti, R., Baldisseri, D. M., Pan, Y., Udan, R., Carrier, F., MacKerell, A. D.Jr., and Weber, D. J. (2004) Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction. J. Med. Chem. 47, 5085-5093.
36. Zhong, S., Macias, A. T., and MacKerell, A. D.Jr. (2007) Computational identification of inhibitors of protein-protein interactions. Curr. Top. Med. Chem. 7, 63-82.
37. Garrett, S. C., Hodgson, L., Rybin, A., Toutchkine, A., Hahn, K. M., Lawrence, D. S., and Bresnick, A. R. (2008) A biosensor of S100A4 metastasis factor activation: Inhibitor screening and cellular activation dynamics. Biochemistry 47, 986-996.
38. Charpentier, T. H., Wilder, P. T., Liriano, M. A., Varney, K. M., Pozharski, E., MacKerell, A. D.Jr., Coop, A., Toth, E. A., and Weber, D. J. (2008) Divalent Metal Ion Complexes of S100B in the Absence and Presence of Pentamidine. J. Mol. Biol. 382, 56.
39. Charpentier, T. H., Wilder, P. T., Liriano, M. A., Varney, K. M., Zhong, S., Coop, A., Pozharski, E., Alexander, D., MacKerell, J., Toth, E. A., and Weber, D. J. (2009) Small Molecules Bound to Unique Sites in the Target Protein Binding Cleft of Calcium-Bound S100B As Characterized by Nuclear Magnetic Resonance and X-ray Crystallography. Biochemistry 48, 6202-6212.
40. Slavik, J. (1982) Anilinonaphthalene sulfonate as a probe of membrane composition and function. Biochim. Biophys. Acta 694, 1-25.
41. Ke, S., Wright, J. C., and Kwon, G. S. (2007) Avidin-biotin-PEG-CPA complexes as potential EPR-directed therapeutic protein carriers: Preparation and characterization. Bioconjugate Chem. 18, 1644-1650. (Pubitemid 47464075)
42. Chaves, J. M., Srivastava, K., Gupta, R., and Srivastava, O. P. (2008) Structural and functional roles of deamidation and/or truncation of N- or C-termini in human αA-crystallin. Biochemistry 47, 10069-10083.
43. Hawe, A., Sutter, M., and Jiskoot, W. (2008) Extrinsic fluorescent dyes as tools for protein characterization. Pharm. Res. 25, 1487-1499.
44. Togashi, D. M., and Ryder, A. G. (2008) A fluorescence analysis of ANS bound to bovine serum albumin: Binding properties revisited by using energy transfer. J. Fluoresc. 18, 519-526.
45. Gasymov, O. K., and Glasgow, B. J. (2007) ANS fluorescence: Potential to augment the identification of the external binding sites of proteins. Biochim. Biophys. Acta 1774, 403-411.
46. Kirk, W., Kurian, E., and Wessels, W. (2007) Photophysics of ANS. V. Decay modes of ANS in proteins: The IFABP-ANS complex. Biophys. Chem. 125, 50-58.
47. Pflugrath, J. (1999) The finer things in X-ray diffraction data collection. Acta Crystallogr. D55, 1718-1725.
48. Collaborative Computational Project Number 4 (1994) The CCP4 Suite: Programs for protein crystallography. Acta Crystallogr. D50, 760-763.
49. Vagin, A., and Teplyakov, A. (1997) MOLREP: An Automated Program for Molecular Replacement. J. Appl. Crystallogr. 1022-1025.
50. Emsley, P., and Cowtan, K. (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr. D60, 2126-2132.
51. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D53, 240-255.
52. Gasymov, O. K., Abduragimov, A. R., and Glasgow, B. J. (2007) Evidence for internal and external binding sites on human tear lipocalin. Arch. Biochem. Biophys. 468, 15-21.
53. Bohne, C. R., and Scaiano, J. C. (1991) Photochemistry in Organized and Constrained Media , VCH Publishers, New York.
54. Gietz, R. D., and Schiestl, R. H. (2007) Quick and easy yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat. Protoc. 2, 35-37.
55. Huang, J., and Bright, F. V. (1990) Unimodal Lorentzian Lifetime Distributions for the 2-Anilinonaphthalene-6-sulfonate-β-Cyclodextrin Inclusion Complex Recovered by Multifrequency Phase-Modulation Fluorometry. J. Phys. Chem. 94, 8457-8463.
56. Kirk, W. R., Kurian, E., and Prendergast, F. G. (1996) Characterization of the sources of protein-ligand affinity: 1-Sulfonato-8-(1′) anilinonaphthalene binding to intestinal fatty acid binding protein. Biophys. J. 70, 69-83. (Pubitemid 126504244)
57. Gasymov, O. K., Abduragimov, A. R., and Glasgow, B. J. (2008) Ligand binding site of tear lipocalin: Contribution of a trigonal cluster of charged residues probed by 8-anilino-1-naphthalenesulfonic acid. Biochemistry 47, 1414-1424.
58. West, N. R., Farnell, B., Murray, J. I., Hof, F., Watson, P. H., and Boulanger, M. J. (2009) Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding. Protein Sci. (in press).